To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SUGT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
322 supporting clones for gene SUGT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001130912.1   SUGT1.a 1 to 1786 1 to 1786 exact RefSeq, AAA   1786/1786
(100 %)
0 diff
(100 %id)
BX371722 Placenta Cot 25-normalized SUGT1.a 14 to 536 520 to 1       520/544
(95 %)
12 diff
(97.8 %id)
BG249168 hypernephroma, cell line, Kidney SUGT1.a 22 to 727 1 to 715   tiling clone,   713/1099
(64 %)
18 diff
(98.4 %id)
CN345939 embryonic stem cells, DMSO-treated H9 cellline SUGT1.a 46 to 463 1 to 418       418/418
(100 %)
0 diff
(100 %id)
DW435203 Liver SUGT1.a 49 to 289 16 to 256       241/256
(94 %)
6 diff
(97.7 %id)
DW456319 Liver SUGT1.a 49 to 202 16 to 169       154/169
(91 %)
6 diff
(96.5 %id)
BI830200 brain, medulla SUGT1.a 49 to 228 22 to 201       180/201
(89 %)
6 diff
(97.1 %id)
BI550879 brain, hippocampus SUGT1.a 60 to 812 6 to 766       761/877
(86 %)
22 diff
(97.5 %id)
TI_44172214   SUGT1.a 60 to 914 90 to 960       849/961
(88 %)
38 diff
(96.1 %id)
AL709430 human skeletal muscle SUGT1.a 116 to 523 1 to 410       408/410
(99 %)
5 diff
(98.8 %id)
AL541132 placenta SUGT1.a 121 to 1166 1 to 1039       1039/1039
(100 %)
15 diff
(98.6 %id)
BI769927 pooled lung and spleen SUGT1.a 121 to 228 1 to 104       104/104
(100 %)
4 diff
(96.2 %id)
BG572448 placenta SUGT1.a 122 to 703 39 to 620       582/821
(70 %)
7 diff
(99.2 %id)
DA246168 brain SUGT1.a 139 to 708 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DW412679 Liver SUGT1.a 141 to 446 18 to 323       306/323
(94 %)
9 diff
(97.3 %id)
AY321358   SUGT1.a 144 to 1359 1 to 1216 exact tiling clone, AAA   1216/1216
(100 %)
0 diff
(100 %id)
BF310138 muscle, rhabdomyosarcoma SUGT1.a 144 to 873 82 to 824       742/900
(82 %)
31 diff
(96.6 %id)
BI115553 muscle, rhabdomyosarcoma SUGT1.a 144 to 843 47 to 753       707/972
(72 %)
20 diff
(98.0 %id)
BP277275 Kidney SUGT1.a 145 to 726 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB466686 hippocampus SUGT1.a 147 to 587 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
DA367524 subthalamic nucleus SUGT1.a 148 to 712 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BM746047 stomach SUGT1.a 148 to 644 10 to 506       497/497
(100 %)
3 diff
(99.4 %id)
BI115089 muscle, rhabdomyosarcoma SUGT1.a 150 to 532 1 to 390       386/390
(98 %)
12 diff
(97.0 %id)
BM549579 astrocytoma grade IV, cell line, brain SUGT1.a 155 to 1133 1 to 988       988/1104
(89 %)
36 diff
(96.8 %id)
CN345932 embryonic stem cells, DMSO-treated H9 cellline SUGT1.a 157 to 793 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BU189007 melanotic melanoma, cell line, skin SUGT1.a 157 to 1032 35 to 920       886/983
(90 %)
17 diff
(98.3 %id)
BU173965 melanotic melanoma, cell line, skin SUGT1.a 159 to 954 1 to 804       804/880
(91 %)
18 diff
(98.0 %id)
BU838738 melanotic melanoma, cell line, skin SUGT1.a 159 to 948 1 to 790       790/917
(86 %)
14 diff
(98.5 %id)
AY271314 brain SUGT1.a 161 to 1562 1 to 1404 A120V tiling clone,   1404/1404
(100 %)
3 diff
(99.8 %id)
BI115106 muscle, rhabdomyosarcoma SUGT1.a 170 to 946 1 to 787       785/830
(94 %)
25 diff
(97.0 %id)
BG575134 breast, mammary adenocarcinoma, cell line SUGT1.a 171 to 771 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BQ226345 embryonal carcinoma, cell line, testis SUGT1.a 172 to 1026 1 to 860       860/861
(99 %)
11 diff
(98.8 %id)
BQ687084 ductal carcinoma, cell line, Pancreas SUGT1.a 175 to 1040 1 to 877       847/881
(96 %)
43 diff
(95.2 %id)
CX165906 human embryonic stem cells differentiated toan early endodermal cell type SUGT1.a 175 to 1013 1 to 840       840/840
(100 %)
2 diff
(99.8 %id)
FN093295 breast carcinoma SUGT1.a 176 to 266 91 to 2     Submitted on the opposite strand 90/99
(90 %)
0 diff
(100 %id)
AK291402 brain SUGT1.a 179 to 1744 1 to 1566 K363R     1566/1566
(100 %)
3 diff
(99.9 %id)
DA525802 brain SUGT1.a 179 to 742 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA793167 brain SUGT1.a 180 to 745 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
BF694016 muscle (skeletal) SUGT1.a 189 to 811 1 to 627       627/840
(74 %)
18 diff
(97.9 %id)
BG497946 adenocarcinoma, Prostate SUGT1.a 195 to 948 1 to 757       757/759
(99 %)
17 diff
(97.8 %id)
CF456914 peripheral nervous system SUGT1.a 196 to 948 44 to 797       752/807
(93 %)
9 diff
(98.9 %id)
AW363086 colon SUGT1.a 210 to 470 18 to 279       260/279
(93 %)
11 diff
(96.1 %id)
BU178082 melanotic melanoma, skin SUGT1.a 219 to 1039 15 to 835       821/861
(95 %)
9 diff
(99.0 %id)
ES308524 beard hair, skin SUGT1.a 250 to 406 1 to 157       157/157
(100 %)
0 diff
(100 %id)
CD515556 White Matter SUGT1.a 274 to 1133 1 to 869       869/888
(97 %)
12 diff
(98.7 %id)
BG573052 placenta SUGT1.a 353 to 1039 1 to 694       694/699
(99 %)
10 diff
(98.6 %id)
BM850038 stomach SUGT1.a 361 to 948 1 to 585       585/593
(98 %)
4 diff
(99.4 %id)
FN136719 breast carcinoma SUGT1.a 469 to 558 1 to 90       90/93
(96 %)
6 diff
(93.6 %id)
BF341027 brain, glioblastoma with EGFR amplification SUGT1.a 482 to 1179 1 to 691       691/692
(99 %)
12 diff
(98.3 %id)
BM853595 Ascites, stomach SUGT1.a 569 to 995 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AA935807 carcinoid, lung SUGT1.a 584 to 1088 1 to 505     Submitted on the opposite strand 505/505
(100 %)
8 diff
(98.5 %id)
BU629854 cell lines, Chondrosarcoma SUGT1.a 628 to 1346 736 to 19   AAA   718/718
(100 %)
2 diff
(99.8 %id)
AI800098 ovary, tumor, 5 pooled (see description) SUGT1.a 643 to 1107 465 to 1       465/471
(98 %)
5 diff
(99.0 %id)
TI_149304153   SUGT1.a 650 to 1341 780 to 89   AAA   692/697
(99 %)
1 diff
(99.9 %id)
TI_154100548   SUGT1.a 653 to 1341 802 to 116   AAA   688/783
(87 %)
8 diff
(99.0 %id)
CN345935 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SUGT1.a 658 to 1116 9 to 467   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 459/468
(98 %)
12 diff
(97.5 %id)
BU173083 melanotic melanoma, skin SUGT1.a 658 to 1139 1 to 481       481/518
(92 %)
8 diff
(98.5 %id)
AA983700 carcinoid, lung SUGT1.a 667 to 1036 1 to 369     Submitted on the opposite strand 369/369
(100 %)
3 diff
(99.2 %id)
AA983708 carcinoid, lung SUGT1.a 667 to 1003 1 to 338     Submitted on the opposite strand 338/338
(100 %)
3 diff
(99.2 %id)
AA773604 lung, lung carcinoma SUGT1.a 668 to 826 159 to 1       159/159
(100 %)
0 diff
(100 %id)
TI_149287462   SUGT1.a 677 to 1130 518 to 68   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 451/1179
(38 %)
1 diff
(100.0 %id)
BM972778 lung SUGT1.a 677 to 1124 449 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 446/457
(97 %)
1 diff
(99.8 %id)
CB530002 Aveolar Macrophage, lung SUGT1.a 679 to 1343 680 to 17   AAA   664/664
(100 %)
2 diff
(99.7 %id)
BM981979 lung, Primary Lung Cystic Fibrosis EpithelialCells SUGT1.a 693 to 1341 667 to 19   AAA   649/649
(100 %)
0 diff
(100 %id)
BM788973 Ascites, stomach SUGT1.a 706 to 1288 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BM790432 Ascites, stomach SUGT1.a 706 to 1312 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
BG392747 embryonal carcinoma, cell line, testis SUGT1.a 712 to 1343 30 to 662       633/671
(94 %)
8 diff
(98.9 %id)
TI_149304979   SUGT1.a 723 to 1341 706 to 88   AAA   619/697
(88 %)
0 diff
(100 %id)
BM978471 lung, Primary Lung Epithelial Cells SUGT1.a 723 to 1341 637 to 19   AAA   619/672
(92 %)
0 diff
(100 %id)
CA748563 Alveolar Macrophage, lung SUGT1.a 727 to 1341 633 to 19   AAA   615/615
(100 %)
1 diff
(99.9 %id)
AA737820 pooled germ cell tumors SUGT1.a 729 to 1107 378 to 1       378/378
(100 %)
3 diff
(99.3 %id)
AA922195 pooled SUGT1.a 733 to 1344 611 to 1       611/611
(100 %)
3 diff
(99.6 %id)
BG183865   SUGT1.a 736 to 1121 1 to 383   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 383/384
(99 %)
10 diff
(97.4 %id)
BG199938   SUGT1.a 736 to 1341 3 to 609   AAA   607/610
(99 %)
7 diff
(98.9 %id)
BM995986 lung, Metastatic Chondrosarcoma SUGT1.a 736 to 1359 643 to 19   AAA   625/625
(100 %)
2 diff
(99.7 %id)
BG191214   SUGT1.a 739 to 1345 1 to 603   AAA   603/604
(99 %)
12 diff
(98.1 %id)
BG186516   SUGT1.a 741 to 1341 1 to 599       599/903
(66 %)
23 diff
(97.5 %id)
BG203036   SUGT1.a 741 to 1341 1 to 596   AAA   596/596
(100 %)
6 diff
(99.0 %id)
BG181793   SUGT1.a 742 to 1317 8 to 582       575/945
(60 %)
13 diff
(98.7 %id)
BG182809   SUGT1.a 742 to 1341 3 to 597   AAA   595/597
(99 %)
7 diff
(98.9 %id)
BG195961   SUGT1.a 742 to 1121 1 to 374   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 374/375
(99 %)
12 diff
(96.8 %id)
BG200960   SUGT1.a 742 to 1121 8 to 384   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 377/385
(97 %)
10 diff
(97.5 %id)
BG201320   SUGT1.a 742 to 1221 1 to 480       480/900
(53 %)
13 diff
(98.6 %id)
BG217774   SUGT1.a 742 to 1345 5 to 604   AAA   600/605
(99 %)
9 diff
(98.6 %id)
BG183358   SUGT1.a 743 to 1341 7 to 602   AAA   596/602
(99 %)
7 diff
(98.9 %id)
BG187028   SUGT1.a 743 to 1341 7 to 601   AAA   595/602
(98 %)
8 diff
(98.7 %id)
BG190725   SUGT1.a 743 to 1341 7 to 601   AAA   595/601
(99 %)
7 diff
(98.9 %id)
BG193312   SUGT1.a 743 to 1341 7 to 601   AAA   595/601
(99 %)
10 diff
(98.4 %id)
BG200443   SUGT1.a 743 to 1340 7 to 600   AAA   594/600
(99 %)
7 diff
(98.9 %id)
BG209821   SUGT1.a 743 to 1346 7 to 606   AAA   600/606
(99 %)
6 diff
(99.1 %id)
BG211360   SUGT1.a 744 to 1341 7 to 601   AAA   595/601
(99 %)
13 diff
(97.9 %id)
BU159242 eye, retinoblastoma SUGT1.a 744 to 1341 634 to 36   AAA Submitted on the opposite strand 599/905
(66 %)
10 diff
(98.9 %id)
BG195960   SUGT1.a 746 to 1223 14 to 493   AAA   480/887
(54 %)
14 diff
(98.5 %id)
AW194609 Kidney SUGT1.a 746 to 1445 705 to 6       700/706
(99 %)
9 diff
(98.8 %id)
BG187027   SUGT1.a 747 to 1341 11 to 601   AAA   591/602
(98 %)
9 diff
(98.6 %id)
TI_149285246   SUGT1.a 747 to 1606 951 to 106   AAA   849/1097
(77 %)
25 diff
(97.8 %id)
BG184911   SUGT1.a 749 to 1346 16 to 612   AAA   597/612
(97 %)
6 diff
(99.1 %id)
BG185451   SUGT1.a 750 to 1345 19 to 612   AAA   594/613
(96 %)
7 diff
(98.9 %id)
BG203035   SUGT1.a 751 to 1345 15 to 606   AAA   592/607
(97 %)
7 diff
(98.9 %id)
BG185450   SUGT1.a 756 to 1341 28 to 612   AAA   585/612
(95 %)
6 diff
(99.1 %id)
BG190239   SUGT1.a 756 to 1342 28 to 613       586/617
(94 %)
10 diff
(98.4 %id)
BM503331 Pancreas, Purified pancreatic islet SUGT1.a 757 to 1360 609 to 6       604/609
(99 %)
0 diff
(100 %id)
BG194316   SUGT1.a 759 to 1341 26 to 605   AAA   580/605
(95 %)
10 diff
(98.4 %id)
BG188614   SUGT1.a 762 to 1342 26 to 604       579/608
(95 %)
10 diff
(98.4 %id)
CF128956 Chondrosarcoma Lung Metastasis cell lines, lung SUGT1.a 762 to 1197 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
TI_154190462   SUGT1.a 762 to 1339 53 to 631       579/1119
(51 %)
22 diff
(98.1 %id)
AW873081 adrenal gland, neuroblastoma SUGT1.a 763 to 1341 591 to 13   AAA   579/579
(100 %)
0 diff
(100 %id)
BG186515   SUGT1.a 765 to 1121 30 to 382   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 353/383
(92 %)
10 diff
(97.4 %id)
BG207728   SUGT1.a 779 to 1321 84 to 623       540/1017
(53 %)
20 diff
(98.1 %id)
BG211900   SUGT1.a 779 to 1121 39 to 378   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 340/379
(89 %)
10 diff
(97.4 %id)
BQ691283 ductal carcinoma, cell line, Pancreas SUGT1.a 781 to 1310 66 to 596       531/1380
(38 %)
41 diff
(97.1 %id)
CK822065 Pancreas, Purified pancreatic islet SUGT1.a 782 to 1360 579 to 1     Submitted on the opposite strand 579/580
(99 %)
7 diff
(98.8 %id)
BM006480 ductal carcinoma, cell line, Pancreas SUGT1.a 786 to 1276 1 to 496   fully sequenced,   496/496
(100 %)
20 diff
(96.0 %id)
TI_59395515   SUGT1.a 787 to 1270 57 to 545       489/669
(73 %)
15 diff
(97.8 %id)
BU174100 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556   AAA   556/556
(100 %)
0 diff
(100 %id)
BU191274 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1341 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BU180384 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556   AAA   556/560
(99 %)
1 diff
(99.9 %id)
BQ877452 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 555   AAA   555/560
(99 %)
2 diff
(99.7 %id)
BQ690083 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556   AAA   556/556
(100 %)
0 diff
(100 %id)
BQ689967 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556   AAA   556/556
(100 %)
0 diff
(100 %id)
BQ689179 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556       556/591
(94 %)
1 diff
(99.9 %id)
BQ686395 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1341 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BQ888386 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1341 1 to 554       554/592
(93 %)
1 diff
(99.9 %id)
BQ878396 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556       556/592
(93 %)
1 diff
(99.9 %id)
BQ690568 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1348 1 to 562       562/591
(95 %)
3 diff
(99.5 %id)
BQ685774 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1341 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BQ685685 ductal carcinoma, cell line, Pancreas SUGT1.a 788 to 1343 1 to 556       556/593
(93 %)
1 diff
(99.9 %id)
TI_151733787   SUGT1.a 795 to 1341 631 to 85   AAA   547/917
(59 %)
0 diff
(100 %id)
BQ187113 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SUGT1.a 796 to 1341 1 to 547   fully sequenced, AAA   547/547
(100 %)
1 diff
(99.9 %id)
AW197591 pooled germ cell tumors SUGT1.a 808 to 1342 539 to 5       535/539
(99 %)
0 diff
(100 %id)
AI185740 lung SUGT1.a 829 to 1342 518 to 5       514/518
(99 %)
0 diff
(100 %id)
BG194315   SUGT1.a 835 to 1341 1 to 506   AAA   506/506
(100 %)
9 diff
(98.3 %id)
BG197327   SUGT1.a 835 to 1347 1 to 509       509/542
(93 %)
17 diff
(96.9 %id)
BG190724   SUGT1.a 837 to 1341 1 to 503   AAA   503/503
(100 %)
9 diff
(98.3 %id)
BG194917   SUGT1.a 837 to 1341 1 to 503   AAA   503/503
(100 %)
7 diff
(98.7 %id)
BG211899   SUGT1.a 837 to 1341 47 to 551   AAA   505/551
(91 %)
11 diff
(98.1 %id)
BG205595   SUGT1.a 839 to 1341 1 to 502   AAA   502/502
(100 %)
5 diff
(99.1 %id)
BG219791   SUGT1.a 842 to 1341 48 to 545   AAA   498/545
(91 %)
7 diff
(98.8 %id)
CN345938 embryonic stem cells, DMSO-treated H9 cellline SUGT1.a 844 to 1340 1 to 497       497/497
(100 %)
0 diff
(100 %id)
AI282285 Kidney, renal cell tumor SUGT1.a 844 to 1114 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AA397353   SUGT1.a 845 to 1221 1 to 374       374/387
(96 %)
5 diff
(98.8 %id)
BG188613   SUGT1.a 848 to 1341 55 to 547   AAA   493/547
(90 %)
17 diff
(96.9 %id)
BG189118   SUGT1.a 848 to 1363 11 to 525   AAA   515/525
(98 %)
12 diff
(97.8 %id)
N47199 multiple sclerosis lesions SUGT1.a 863 to 1073 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
AA176983   SUGT1.a 867 to 1353 1 to 477       477/490
(97 %)
28 diff
(94.3 %id)
AA640513   SUGT1.a 867 to 1320 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
AI149726   SUGT1.a 880 to 1341 477 to 16   AAA   462/476
(97 %)
1 diff
(99.8 %id)
BM727854 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SUGT1.a 883 to 1571 1 to 687   fully sequenced,   687/687
(100 %)
3 diff
(99.6 %id)
BG117398 adenocarcinoma, cell line, Liver SUGT1.a 890 to 1583 1 to 686       686/919
(74 %)
18 diff
(98.1 %id)
DB508874 testis SUGT1.a 894 to 1339 1 to 445     Submitted on the opposite strand 445/447
(99 %)
7 diff
(98.5 %id)
AU309848 neuroblastoma SUGT1.a 896 to 1341 499 to 54       446/499
(89 %)
0 diff
(100 %id)
BM984697 lung SUGT1.a 898 to 1606 725 to 17   AAA   709/709
(100 %)
2 diff
(99.8 %id)
BF341862 brain, glioblastoma with EGFR amplification SUGT1.a 899 to 1339 69 to 507       439/726
(60 %)
7 diff
(99.1 %id)
BF341904 brain, glioblastoma with EGFR amplification SUGT1.a 899 to 1346 69 to 513   AAA   447/513
(87 %)
9 diff
(98.3 %id)
CA429588 Cell Line, Chondrosarcoma SUGT1.a 914 to 1606 708 to 17   AAA   692/692
(100 %)
2 diff
(99.8 %id)
BX104850 Kidney SUGT1.a 918 to 1341 1 to 424   AAA   424/424
(100 %)
0 diff
(100 %id)
BQ010259 Chondrosarcoma, Left Pubic Bone SUGT1.a 939 to 1571 651 to 19   AAA   633/633
(100 %)
1 diff
(99.9 %id)
BE876387 large cell carcinoma, undifferentiated, lung SUGT1.a 944 to 1340 1 to 397       397/397
(100 %)
0 diff
(100 %id)
AA713593 germinal center B cell SUGT1.a 947 to 1341 413 to 20   AAA   394/399
(98 %)
1 diff
(99.8 %id)
AI628310 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SUGT1.a 947 to 1341 394 to 1       394/396
(99 %)
1 diff
(99.8 %id)
AW449858   SUGT1.a 947 to 1346 418 to 18   AAA   401/421
(95 %)
1 diff
(99.8 %id)
BG188615   SUGT1.a 949 to 1329 1 to 381       381/386
(98 %)
1 diff
(99.8 %id)
BF110474 carcinoid, lung SUGT1.a 949 to 1343 399 to 5       395/399
(98 %)
2 diff
(99.5 %id)
CB069228 Pancreas, Purified pancreatic islet SUGT1.a 955 to 1571 617 to 1       617/617
(100 %)
2 diff
(99.7 %id)
DB565393 hypothalamus SUGT1.a 964 to 1363 1 to 400   AAA Submitted on the opposite strand 400/400
(100 %)
5 diff
(98.8 %id)
AA704143 bone marrow stroma SUGT1.a 971 to 1343 396 to 24   AAA   373/373
(100 %)
0 diff
(100 %id)
BM007054 ductal carcinoma, cell line, Pancreas SUGT1.a 977 to 1273 320 to 21   fully sequenced,   300/320
(93 %)
2 diff
(99.4 %id)
AA702002 liver and spleen SUGT1.a 982 to 1621 640 to 1       640/640
(100 %)
3 diff
(99.6 %id)
BU679631 lung, Primary Lung Epithelial Cells SUGT1.a 984 to 1339 376 to 21   AAA   356/358
(99 %)
5 diff
(98.7 %id)
BQ438035 leiomyosarcoma, uterus SUGT1.a 989 to 1346 1 to 358   AAA   358/358
(100 %)
0 diff
(100 %id)
BU741531 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SUGT1.a 1009 to 1586 595 to 19   fully sequenced, AAA   577/577
(100 %)
2 diff
(99.7 %id)
CK300334 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SUGT1.a 1009 to 1341 351 to 19   fully sequenced, AAA   333/333
(100 %)
0 diff
(100 %id)
AA863436 Kidney SUGT1.a 1017 to 1343 331 to 5       327/331
(98 %)
1 diff
(99.7 %id)
CB115880 Liver SUGT1.a 1017 to 1341 343 to 19   AAA Submitted on the opposite strand 325/325
(100 %)
3 diff
(99.1 %id)
F30845 pectoral muscle (after mastectomy) SUGT1.a 1039 to 1136 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AA975245 pooled germ cell tumors SUGT1.a 1042 to 1341 324 to 25   AAA   300/300
(100 %)
0 diff
(100 %id)
AI915421 pooled SUGT1.a 1051 to 1255 205 to 1       205/205
(100 %)
0 diff
(100 %id)
AI471343 colon, moderately-differentiated adenocarcinoma SUGT1.a 1057 to 1341 285 to 1       285/285
(100 %)
0 diff
(100 %id)
DA309130 hippocampus SUGT1.a 1063 to 1646 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
AW965126   SUGT1.a 1071 to 1736 1 to 666       666/667
(99 %)
3 diff
(99.6 %id)
BE081596 breast SUGT1.a 1075 to 1426 1 to 350       350/350
(100 %)
3 diff
(99.2 %id)
AI610316 serous papillary carcinoma, high grade, 2pooled tumors, uterus SUGT1.a 1078 to 1318 241 to 1       241/241
(100 %)
15 diff
(93.8 %id)
AI913509 Kidney SUGT1.a 1078 to 1571 494 to 1       494/494
(100 %)
6 diff
(98.8 %id)
BE081889 breast SUGT1.a 1080 to 1442 1 to 368       368/368
(100 %)
17 diff
(95.4 %id)
T32544 gallbladder SUGT1.a 1088 to 1400 1 to 313       313/313
(100 %)
3 diff
(99.1 %id)
AA046362 heart SUGT1.a 1107 to 1341 235 to 1     Submitted on the opposite strand 235/235
(100 %)
1 diff
(99.6 %id)
AA724214 parathyroid gland, parathyroid tumor SUGT1.a 1117 to 1572 463 to 7       457/463
(98 %)
2 diff
(99.6 %id)
BM988188 mixed SUGT1.a 1126 to 1341 234 to 19   AAA   216/216
(100 %)
0 diff
(100 %id)
AA714758 germinal center B-cells, tonsil SUGT1.a 1134 to 1571 449 to 12   AAA   438/449
(97 %)
6 diff
(98.7 %id)
D19789   SUGT1.a 1170 to 1342 1 to 173     Submitted on the opposite strand 173/175
(98 %)
3 diff
(98.3 %id)
BE082127 breast SUGT1.a 1225 to 1514 289 to 2     Submitted on the opposite strand 288/301
(95 %)
0 diff
(100 %id)
AI678909 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SUGT1.a 1232 to 1445 215 to 2       214/215
(99 %)
0 diff
(100 %id)
AA847404 ovary SUGT1.a 1322 to 1572 256 to 6       251/263
(95 %)
0 diff
(100 %id)
AA927478 pooled SUGT1.a 1352 to 1779 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
BP420857 small intestine SUGT1.a 1463 to 1781 1 to 319   tiling clone, Submitted on the opposite strand 319/321
(99 %)
2 diff
(99.4 %id)
CN345940 embryonic stem cells, cell lines H1, H7, andH9 SUGT1.b 1 to 582 1 to 585   tiling clone,   585/585
(100 %)
2 diff
(99.7 %id)
NM_006704.3   SUGT1.b 6 to 1695 1 to 1690 exact RefSeq, AAA   1690/1690
(100 %)
0 diff
(100 %id)
BP225371   SUGT1.b 7 to 584 1 to 580       578/580
(99 %)
14 diff
(97.6 %id)
TI_57170929   SUGT1.b 54 to 934 22 to 908       885/956
(92 %)
31 diff
(96.8 %id)
BG337219 leiomyosarcoma cell line, uterus SUGT1.b 58 to 912 1 to 859       859/859
(100 %)
10 diff
(98.9 %id)
BG339592 leiomyosarcoma cell line, uterus SUGT1.b 58 to 848 1 to 788       788/909
(86 %)
14 diff
(98.5 %id)
BG337057 leiomyosarcoma cell line, uterus SUGT1.b 59 to 749 1 to 686       686/944
(72 %)
14 diff
(98.6 %id)
BE732105 choriocarcinoma, placenta SUGT1.b 71 to 722 1 to 656       656/820
(80 %)
7 diff
(99.2 %id)
DT216726 brain SUGT1.b 118 to 698 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
TI_57183351   SUGT1.b 126 to 706 103 to 678       574/679
(84 %)
8 diff
(98.9 %id)
BG742472 skin SUGT1.b 132 to 871 1 to 741       741/959
(77 %)
11 diff
(98.9 %id)
AJ344097   SUGT1.b 138 to 1543 1 to 1406 exact tiling clone,   1406/1555
(90 %)
9 diff
(99.5 %id)
BI459723 testis SUGT1.b 139 to 866 1 to 736       735/783
(93 %)
23 diff
(97.1 %id)
AK292128 synovial membrane tissue from rheumatoidarthritis SUGT1.b 143 to 1751 1 to 1611 N163D A239V tiling clone,   1611/1611
(100 %)
4 diff
(99.8 %id)
DA989049 synovial membrane tissue from rheumatioidarthritis SUGT1.b 144 to 721 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BM849524 myeloma SUGT1.b 146 to 804 1 to 659       659/659
(100 %)
0 diff
(100 %id)
DT218320 brain SUGT1.b 150 to 822 1 to 673       673/673
(100 %)
0 diff
(100 %id)
BM839833 myeloma SUGT1.b 150 to 700 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BM782902 myeloma SUGT1.b 150 to 634 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BM849743 myeloma SUGT1.b 150 to 702 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BM850062 myeloma SUGT1.b 150 to 777 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BM788909 stomach SUGT1.b 150 to 724 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BE732149 choriocarcinoma, placenta SUGT1.b 151 to 935 1 to 775       773/827
(93 %)
12 diff
(98.6 %id)
BG501612 embryonal carcinoma, testis SUGT1.b 151 to 838 1 to 693       695/834
(83 %)
19 diff
(97.8 %id)
DB443943 testis SUGT1.b 152 to 599 1 to 450       450/450
(100 %)
1 diff
(99.8 %id)
TI_57173941   SUGT1.b 156 to 872 24 to 741       716/743
(96 %)
8 diff
(99.0 %id)
CF455869 peripheral nervous system SUGT1.b 160 to 877 23 to 740       716/740
(96 %)
8 diff
(99.0 %id)
TI_57216798   SUGT1.b 160 to 992 23 to 856       832/856
(97 %)
20 diff
(97.7 %id)
CN345931 embryonic stem cells, DMSO-treated H9 cellline SUGT1.b 161 to 871 1 to 711       711/711
(100 %)
0 diff
(100 %id)
BX406592 fetal liver, Liver SUGT1.b 161 to 932 1 to 774   fully sequenced,   774/774
(100 %)
4 diff
(99.5 %id)
CX757670 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SUGT1.b 162 to 856 1 to 691     Submitted on the opposite strand 691/800
(86 %)
9 diff
(98.9 %id)
TI_57171098   SUGT1.b 168 to 965 31 to 849       812/849
(95 %)
34 diff
(96.0 %id)
BF345673 anaplastic oligodendroglioma with 1p/19qloss, brain SUGT1.b 172 to 946 1 to 776       774/1127
(68 %)
26 diff
(97.7 %id)
AL540409 placenta SUGT1.b 174 to 888 1 to 715   fully sequenced,   715/715
(100 %)
1 diff
(99.9 %id)
BI830339 brain, medulla SUGT1.b 174 to 965 1 to 813       808/813
(99 %)
29 diff
(96.5 %id)
CX761448 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SUGT1.b 174 to 752 35 to 609     Submitted on the opposite strand 573/745
(76 %)
14 diff
(98.2 %id)
BI093218 cervix SUGT1.b 175 to 948 1 to 772       772/778
(99 %)
12 diff
(98.5 %id)
BC000911 Cervix, carcinoma SUGT1.b 176 to 1695 1 to 1520 exact available from MGC, AAA   1520/1520
(100 %)
1 diff
(100.0 %id)
BG744300 blood, natural killer cells, cell line SUGT1.b 176 to 857 1 to 688       688/844
(81 %)
7 diff
(99.2 %id)
BG744220 blood, natural killer cells, cell line SUGT1.b 176 to 899 1 to 728       726/728
(99 %)
19 diff
(97.4 %id)
BU176954 melanotic melanoma, skin SUGT1.b 177 to 949 1 to 779       779/877
(88 %)
7 diff
(99.3 %id)
AW675226 cervical carcinoma cell line, cervix SUGT1.b 179 to 624 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
CA495287   SUGT1.b 180 to 1048 1 to 870       870/874
(99 %)
6 diff
(99.4 %id)
BG546377 lung SUGT1.b 181 to 986 1 to 812       810/821
(98 %)
20 diff
(97.6 %id)
TI_57171958   SUGT1.b 181 to 985 31 to 834       802/834
(96 %)
7 diff
(99.2 %id)
CN345936 embryonic stem cells, DMSO-treated H9 cellline SUGT1.b 186 to 749 1 to 564       564/569
(99 %)
2 diff
(99.7 %id)
DR762314 embryonic stem SUGT1.b 186 to 1006 1 to 823       823/823
(100 %)
1 diff
(99.9 %id)
CN345937 embryonic stem cells, DMSO-treated H9 cellline SUGT1.b 187 to 810 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BG763977 melanotic melanoma, high MDR (cell line), skin SUGT1.b 189 to 1037 1 to 854       854/875
(97 %)
22 diff
(97.5 %id)
BG764892 melanotic melanoma, high MDR (cell line), skin SUGT1.b 189 to 1016 1 to 840       837/887
(94 %)
27 diff
(97.0 %id)
CN345933 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SUGT1.b 190 to 778 1 to 589       589/589
(100 %)
0 diff
(100 %id)
DT218309 brain SUGT1.b 191 to 836 1 to 646       646/646
(100 %)
0 diff
(100 %id)
BF684799 leiomyosarcoma cell line, uterus SUGT1.b 198 to 936 1 to 728       731/923
(79 %)
14 diff
(98.5 %id)
AA305846   SUGT1.b 202 to 699 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
BM503492 Pancreas, Purified pancreatic islet SUGT1.b 214 to 821 1 to 608       608/608
(100 %)
0 diff
(100 %id)
CN345934 embryonic stem cells, DMSO-treated H9 cellline SUGT1.b 218 to 711 8 to 501       492/501
(98 %)
6 diff
(98.9 %id)
CD700901 normal nasopharynx SUGT1.b 222 to 784 22 to 579       558/579
(96 %)
12 diff
(98.0 %id)
AF132856   SUGT1.b 231 to 1232 1 to 1002 exact     1002/1002
(100 %)
0 diff
(100 %id)
BT009798   SUGT1.b 231 to 1231 1 to 1001       1001/1002
(99 %)
1 diff
(100.0 %id)
BU173411 leiomyosarcoma, uterus SUGT1.b 236 to 1030 1 to 793   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 793/796
(99 %)
6 diff
(99.3 %id)
BM801743 duodenal adenocarcinoma, cell line, small intestine SUGT1.b 238 to 857 1 to 623       623/989
(62 %)
17 diff
(98.3 %id)
BG679492 skin, squamous cell carcinoma SUGT1.b 268 to 1035 1 to 772       772/772
(100 %)
8 diff
(99.0 %id)
CD677440 eye, Trabecular meshwork SUGT1.b 320 to 863 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BX380060 Placenta Cot 25-normalized SUGT1.b 329 to 1228 905 to 1       905/905
(100 %)
6 diff
(99.4 %id)
TI_227713456   SUGT1.b 337 to 1252 994 to 86   AAA   909/979
(92 %)
26 diff
(97.4 %id)
BX351799 Placenta Cot 25-normalized SUGT1.b 343 to 1254 913 to 1       913/914
(99 %)
15 diff
(98.4 %id)
BQ438248 leiomyosarcoma, uterus SUGT1.b 348 to 1183 1 to 840       840/843
(99 %)
6 diff
(99.3 %id)
BP207761 coronary artery SUGT1.b 350 to 932 1 to 583       583/583
(100 %)
16 diff
(97.3 %id)
BP269376 thyroid SUGT1.b 365 to 944 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
TI_149286046   SUGT1.b 412 to 1039 671 to 47   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 625/880
(71 %)
19 diff
(97.9 %id)
BM558644 amelanotic melanoma, cell line, skin SUGT1.b 417 to 1250 1 to 835   AAA   835/835
(100 %)
4 diff
(99.6 %id)
BM912549 amelanotic melanoma, cell line, skin SUGT1.b 418 to 1250 1 to 834   AAA   834/834
(100 %)
4 diff
(99.6 %id)
BM916317 amelanotic melanoma, cell line, skin SUGT1.b 418 to 1251 1 to 841   AAA   841/841
(100 %)
13 diff
(98.5 %id)
BG398487 B-cells, primary B-cells from tonsils (cell line) SUGT1.b 448 to 1038 1 to 589   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 589/589
(100 %)
7 diff
(98.9 %id)
BG342098 B-cells, primary B-cells from tonsils (cell line) SUGT1.b 448 to 1044 1 to 592       592/691
(85 %)
15 diff
(97.9 %id)
BG685753 B-cells, primary B-cells from tonsils (cell line) SUGT1.b 448 to 1014 1 to 577       577/695
(83 %)
18 diff
(97.5 %id)
BG756129 B-cells, primary B-cells from tonsils (cell line) SUGT1.b 448 to 1039 1 to 589   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 589/590
(99 %)
8 diff
(98.7 %id)
BU680897 lung SUGT1.b 487 to 1033 548 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 545/553
(98 %)
3 diff
(99.5 %id)
BQ673377 epidermoid carcinoma, cell line, salivary gland SUGT1.b 494 to 1250 1 to 757   AAA   757/759
(99 %)
5 diff
(99.4 %id)
CA748527 Alveolar Macrophage, lung SUGT1.b 514 to 1250 754 to 19   AAA   736/736
(100 %)
2 diff
(99.8 %id)
CD364442 Alveolar Macrophage, lung SUGT1.b 539 to 1252 729 to 17   AAA   713/713
(100 %)
2 diff
(99.8 %id)
AL568394 placenta SUGT1.b 827 to 1441 845 to 231   fully sequenced,   615/845
(72 %)
2 diff
(99.8 %id)
BX406591 fetal liver, Liver SUGT1.b 902 to 1626 733 to 7   fully sequenced,   727/733
(99 %)
7 diff
(99.1 %id)
AW674699 cervical carcinoma cell line, cervix SUGT1.b 1272 to 1695 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AA312842   SUGT1.c 1 to 583 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
BQ687202 ductal carcinoma, cell line, Pancreas SUGT1.c 1 to 866 1 to 875   tiling clone,   875/903
(96 %)
12 diff
(98.7 %id)
BQ690991 ductal carcinoma, cell line, Pancreas SUGT1.c 1 to 784 1 to 790       790/926
(85 %)
14 diff
(98.5 %id)
AW965809   SUGT1.c 2 to 631 1 to 627       628/627
(100 %)
16 diff
(97.5 %id)
DN995623 breast cancer, Mammary gland (cancer tissue) SUGT1.c 2 to 591 1 to 592       590/592
(99 %)
5 diff
(99.2 %id)
BU174379 ductal carcinoma, cell line, Pancreas SUGT1.c 13 to 783 1 to 783       783/901
(86 %)
15 diff
(98.4 %id)
BQ690070 ductal carcinoma, cell line, Pancreas SUGT1.c 18 to 784 1 to 778       778/998
(77 %)
12 diff
(98.8 %id)
BQ691354 ductal carcinoma, cell line, Pancreas SUGT1.c 18 to 931 1 to 917 E249K R252K W253M E254G L256A ... tiling clone,   917/925
(99 %)
15 diff
(98.4 %id)
BQ896597 ductal carcinoma, cell line, Pancreas SUGT1.c 18 to 675 1 to 658       658/945
(69 %)
6 diff
(99.4 %id)
AL521968 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized SUGT1.d 1 to 772 10 to 781   tiling clone,   770/781
(98 %)
7 diff
(99.2 %id)
AK302363 testis SUGT1.d 144 to 1806 1 to 1663 L18P G72S tiling clone,   1663/1663
(100 %)
3 diff
(99.9 %id)
DB059576 testis SUGT1.d 145 to 645 2 to 503   capped   502/502
(100 %)
2 diff
(99.7 %id)
AA442519   SUGT1.e 1 to 340 1 to 339   tiling clone,   339/339
(100 %)
1 diff
(99.8 %id)
BE537520 cervix SUGT1.e 168 to 857 1 to 688       688/1009
(68 %)
15 diff
(98.6 %id)
CA842003 Pancreas, Purified pancreatic islet SUGT1.e 180 to 797 1 to 618   tiling clone, fully sequenced,   618/618
(100 %)
0 diff
(100 %id)
CA841709 Pancreas, Purified pancreatic islet SUGT1.e 736 to 1158 423 to 1   tiling clone, fully sequenced,   423/423
(100 %)
0 diff
(100 %id)
BQ014480 Chondrosarcoma, Left Pubic Bone SUGT1.f 1 to 755 772 to 19 V99A tiling clone, AAA   754/754
(100 %)
2 diff
(99.8 %id)
BG492429 lung, mucoepidermoid carcinoma SUGT1.g 1 to 633 1 to 630   tiling clone,   630/631
(99 %)
7 diff
(98.9 %id)
TI_149308626   SUGT1.g 470 to 1163 799 to 108   tiling clone, AAA   692/907
(76 %)
2 diff
(99.8 %id)
BM979808 lung, Primary Lung Epithelial Cells SUGT1.g 540 to 1163 642 to 19   AAA   624/624
(100 %)
0 diff
(100 %id)
CR624815 placenta SUGT1.h 1 to 1102 1 to 1102 exact tiling clone,   1102/1102
(100 %)
0 diff
(100 %id)
R84594 brain SUGT1.h 1010 to 1392 15 to 397   tiling clone,   383/431
(88 %)
6 diff
(98.7 %id)
R85481 brain SUGT1.h 1766 to 2157 395 to 1   tiling clone,   395/395
(100 %)
3 diff
(99.3 %id)
AA470048   SUGT1.i 1 to 305 7 to 310   tiling clone, fully sequenced,   310/310
(100 %)
3 diff
(99.1 %id)
AA416876   SUGT1.i 244 to 653 412 to 3   tiling clone, fully sequenced,   410/412
(99 %)
0 diff
(100 %id)
CR610986 fetal liver SUGT1.j 1 to 1473 1 to 1473 exact tiling clone,   1473/1473
(100 %)
0 diff
(100 %id)
CR607917 placenta SUGT1.j 14 to 1478 1 to 1465 exact tiling clone,   1465/1465
(100 %)
0 diff
(100 %id)
AW873417 normal epithelium, thyroid SUGT1.k-u 1 to 417 436 to 21   tiling clone,   416/436
(95 %)
0 diff
(100 %id)
DN912319   SUGT1.k-u 331 to 879 1 to 546   tiling clone,   546/546
(100 %)
5 diff
(99.1 %id)
CR616065 fetal brain SUGT1.k-u 468 to 3269 1 to 2802 exact tiling clone,   2802/2802
(100 %)
0 diff
(100 %id)
AL538302 brain, fetal brain SUGT1.k-u 468 to 1326 1 to 860       860/860
(100 %)
1 diff
(99.9 %id)
BX409581 brain, fetal brain SUGT1.k-u 1159 to 2030 1 to 872 V15I     872/883
(98 %)
24 diff
(97.3 %id)
BX409837 brain, fetal brain SUGT1.k-u 1220 to 2132 1 to 920 V15I     920/924
(99 %)
53 diff
(94.3 %id)
FN050902 breast carcinoma SUGT1.k-u 1563 to 1692 130 to 1     Submitted on the opposite strand 130/131
(99 %)
0 diff
(100 %id)
BX433147 brain, fetal brain SUGT1.k-u 1572 to 2493 923 to 1       923/924
(99 %)
0 diff
(100 %id)
BE082188 breast SUGT1.k-u 1760 to 1885 1 to 127       127/127
(100 %)
2 diff
(98.5 %id)
EH334793   SUGT1.k-u 2211 to 2280 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
FN108459 breast carcinoma SUGT1.k-u 2262 to 2352 1 to 94       94/95
(98 %)
4 diff
(95.8 %id)
AL567242 brain, fetal brain SUGT1.k-u 2355 to 3269 914 to 1       914/914
(100 %)
13 diff
(98.6 %id)
TI_151740813   SUGT1.k-u 2599 to 3027 183 to 612     Submitted on the opposite strand 430/1132
(37 %)
21 diff
(98.2 %id)
BM706744 eye, optic nerve SUGT1.k-u 2802 to 3294 513 to 21   tiling clone, Submitted on the opposite strand 493/513
(96 %)
0 diff
(100 %id)
DA804311 brain SUGT1.l 1 to 549 2 to 551 exact tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
CV410855 uterus_tumor SUGT1.m-u 1 to 304 1 to 304 T2R L3S L4S R5L A7E ... tiling clone,   304/304
(100 %)
21 diff
(93.1 %id)
AF068289   Gene SUGT1, variant not shown         Suspected internal deletion, this clone was ignored    
AW838402 leiomios Gene SUGT1, variant not shown         This clone was ignored    
DB306957 caudate nucleus Gene SUGT1, variant not shown         This clone was ignored    
DA269542 caudate nucleus Gene SUGT1, variant not shown       capped This clone was ignored    
EL594352 epidermis, skin Gene SUGT1, variant not shown         Submitted on the opposite strand    
W95937 heart Gene SUGT1, variant not shown         This clone was ignored    
W95938 heart Gene SUGT1, variant not shown         This clone was ignored    
BF973626 leiomyosarcoma cell line, uterus Gene SUGT1, variant not shown         This clone was ignored    
BM006515 ductal carcinoma, cell line, Pancreas Gene SUGT1, variant not shown         This clone was ignored    
BQ883496 melanotic melanoma, cell line, skin Gene SUGT1, variant not shown              
TI_59395572   Gene SUGT1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI